文献速递妇产影像泌尿生殖技术与安全MR

影像学在妇科恶性肿瘤保留生育功能治疗中的作用

Role of Imaging in Fertility-sparing Treatment of Gynecologic Malignancies.
PubMed 文献 · Radiographics · 2016-01-01

本文基于文献综述,描述目前可用的妇科恶性肿瘤保留生育功能治疗方案,并概述影像学在选择合适患者中的作用:宫颈癌用MR成像确定肿瘤大小、位置和分期以筛选适合根治性子宫颈切除术者;附件复杂肿块用扩散和灌注加权MR序列分类侵袭性或交界性恶性风险以考虑单侧卵巢切除;子宫内膜癌激素治疗前用MR成像排除侵袭性疾病征象;随访中影像用于检测复发但证据有限。

要点

  • 宫颈癌:MR成像用于明确肿瘤大小、位置和分期,以筛选适合根治性子宫颈切除术的患者。
  • 附件孤立复杂肿块:扩散和灌注加权MR序列用于分类侵袭性或交界性恶性可能,以考虑单侧卵巢切除并尽可能保留生育功能。
  • 子宫内膜癌:考虑激素治疗前用MR成像排除侵袭性疾病征象;随访影像检测复发的证据有限。

核心结论

  • 影像学是考虑保留生育功能治疗的妇科恶性肿瘤患者诊疗中的必要工具。

研究设计与样本

  • 本文为基于文献综述的综述性文章,描述目前可用的保留生育功能治疗方案并概述影像学在筛选合适患者中的作用。

关键影像表现/征象

  • 宫颈癌:MR成像用于描绘肿瘤的大小、位置和分期。
  • 附件孤立复杂肿块:扩散和灌注加权MR成像序列用于分类侵袭性或交界性恶性的可能性。
  • 子宫内膜癌:MR成像用于在考虑激素治疗前排除侵袭性疾病征象。

诊断标准与关键数值

  • 宫颈癌:MR成像用于描绘肿瘤大小、位置和分期,以选择适合根治性子宫颈切除术的患者。
  • 附件孤立复杂肿块:扩散和灌注加权MR序列用于分类侵袭性或交界性恶性的可能性,以考虑单侧卵巢切除并尽可能保留生育功能。
  • 子宫内膜癌:MR成像用于在考虑激素治疗前排除侵袭性疾病征象。

临床应用与阅片要点

  • 宫颈癌保留生育功能评估中,用MR成像明确肿瘤大小、位置和分期以筛选根治性子宫颈切除术候选者。
  • 附件孤立复杂肿块的保留生育功能评估中,用扩散和灌注加权MR序列分类侵袭性或交界性恶性可能。
  • 子宫内膜癌考虑激素治疗前,用MR成像排除侵袭性疾病征象。
  • 随访中影像用于检测复发,但支持该应用的证据有限。

局限性

  • 原文指出支持影像学用于随访检测复发这一应用的证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Treatments for gynecologic cancer usually result in loss of fertility due to surgery or radical radiation therapy in the pelvis. In countries with an established screening program for cervical cancer, the majority of gynecologic malignancies occur in postmenopausal women. However, a substantial number of affected women are of childbearing age and have not completed their families. In these younger women, consideration of fertility preservation may be important. This article describes the fertility-sparing treatment options that are currently available and outlines the role of imaging in the selection of eligible patients on the basis of a review of the literature. In the setting of cervical cancer, magnetic resonance (MR) imaging is used to delineate the size, position, and stage of the tumor for selection of patients who are suitable for radical trachelectomy. In patients with solitary complex adnexal masses, diffusion- and perfusion-weighted MR imaging sequences are used to categorize the likelihood of invasive or borderline malignancy for consideration of unilateral ovarian resection, with fertility preservation when possible. In patients with endometrial cancer, MR imaging is used to rule out signs of invasive disease before hormone therapy is considered. Imaging is also used at patient follow-up to detect recurrent disease; however, evidence to support this application is limited. In conclusion, imaging is an essential tool in the care of patients with gynecologic malignancies who are considering fertility-preserving treatment options. ©RSNA, 2016.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Rockall AG, Qureshi M, Papadopoulou I, et al. Role of Imaging in Fertility-sparing Treatment of Gynecologic Malignancies. Radiographics. 2016. PMID: 27831834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。